NCT06408740

Brief Summary

The aim of this study was to examine the effect of physical activity level on social participation, functioning and quality of life in patients with psychosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
157

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 20, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 20, 2024

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

May 7, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 10, 2024

Completed
Last Updated

May 10, 2024

Status Verified

May 1, 2024

Enrollment Period

6 months

First QC Date

May 7, 2024

Last Update Submit

May 7, 2024

Conditions

Keywords

PsychosisSocial ParticipationFunctioningQuality of LifePhysical Activity

Outcome Measures

Primary Outcomes (7)

  • Positive and Negative Syndrome Scale

    The scale is a 30-item semi-structured interview scale with a seven-point severity rating. In our study, individuals scoring below 70 points were included to confirm that the participants were not in the active disease period.

    6 months

  • Calgary Schizophrenia Depression Scale

    The scale is an interviewer-rated scale and consists of 9 items in four-point Likert type. The cut-off score for schizophrenia accompanied by depressive disorder was determined as 11/12. In our study, individuals scoring below 11 points were included to confirm that the participants were not in a depressive episode.

    6 months

  • Glasgow Antipsychotic Side Effect Rating Scale

    It is a 22-item self-report scale about the side effects of antipsychotics. An increase in the scale score indicates an increase in the severity of side effects

    6 months

  • International Physical Activity Form

    This form consists of seven questions and provides information on sitting, walking, moderately vigorous activities and time spent in vigorous activities. The calculation of the total score of the short form includes the sum of duration (minutes) and frequency (days) of walking, moderately vigorous activity and vigorous activity. The sitting score (sedentary behavior level) is calculated separately. Physical activity levels are classified as physically inactive/inactive (\<600 MET-min/week), physically inactive/minimally active (600-3000 MET-min/week) and physically active/very active (\>3000 MET-min/week).

    6 months

  • Community Participation Survey

    It is a method used to observe an individual's participation in the community. It consists of 15 headings. It is used to assess individuals' home, family life, social activities and work activities. Home activity is 10 points; social activity is 12 points and work activity is 7 points. The total score from 0 to 29 is calculated.

    6 months

  • Brief Functioning Assessment Scale

    This scale, which will be used by the researchers, consists of questions designed to measure the extent to which patients experienced difficulties in autonomy, occupational functioning, cognitive functioning, financial issues, interpersonal relations, and leisure time activities during the study. The 24-item scale allows the measurement of 6 different domains of specific functioning: autonomy, occupational, cognitive, financial, interpersonal and leisure activities. The scale provides a total score as well as scores specific to sub-functioning domains. Items are scored according to their severity on a scale of 0 to 4. (0) = no difficulty, (1) = mild difficulty, (2) = moderate difficulty, (3) = severe difficulty. Scores on the scale can range from 0 to 72. A total score above 11 indicates a significant loss of functioning.

    6 months

  • Nottingham Health Profile

    It is used to assess the quality of life of individuals. It consists of 2 parts. The first part includes six categories of energy, pain, physical mobility, sleep, emotional reactions and social isolation and consists of 38 different questions with yes or no answers. The second part consists of 7 questions. The questionnaire asks about current complaints. Positive answers to specific areas are used to assess severity or the sum of the six categories can be given as a profile. The total score for each of the 6 sub-parameters is between 0 and 100 and the total score for the total score is between 0 and 600. A high score indicates poor quality of life.

    6 months

Eligibility Criteria

Age20 Years - 60 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly female
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Psychosis patients

You may qualify if:

  • Patients diagnosed with schizophrenia and other psychotic disorders according to DSM-V criteria (brief psychosis disorder, schizophreniform disorder, schizoaffective disorder, other disorder with psychosis within the scope of another defined schizophrenia and other disorders with psychosis, other disorders with psychosis within the scope of undefined schizophrenia and other disorders with psychosis), who have had their first episode, who are receiving outpatient treatment
  • Whose duration of illness is longer than 2 years
  • Being between the ages of 18-65
  • Being literate

You may not qualify if:

  • The participant is in a period of active illness that makes it difficult to conduct research (Positive and Negative Syndrome Scale\>70 scale points, Calgary Depression in Schizophrenia Scale score \>11 scale points)
  • Comorbid psychiatric illness
  • The patient has an acute or chronic physical illness that impairs the general medical condition and a disease that will affect cognitive functions (neurological, neoplastic, endocrine and immune disorders, infection, epilepsy or any neurological disease, etc.).
  • The patient has a physical illness (loss of limbs, paralysis, etc.) that requires additional care and causes significant disability
  • Alcohol and substance use disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bandırma Onyedi Eylül University

Balıkesir, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Psychotic DisordersMotor Activity

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental DisordersBehavior

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

May 7, 2024

First Posted

May 10, 2024

Study Start

September 20, 2023

Primary Completion

March 20, 2024

Study Completion

April 20, 2024

Last Updated

May 10, 2024

Record last verified: 2024-05

Locations